Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
NovaBay Pharmaceuticals revenue
NovaBay Pharmaceuticals's revenue is $14.4 million.
What is NovaBay Pharmaceuticals's revenue?
- NovaBay Pharmaceuticals's revenue growth from 2014 to 2022 is 1,266.6%.
- NovaBay Pharmaceuticals has 25 employees, and the revenue per employee ratio is $576,160.
- NovaBay Pharmaceuticals's peak quarterly revenue was $2.6M in 2024(q1).
- NovaBay Pharmaceuticals peak revenue was $18.2M in 2017.
- NovaBay Pharmaceuticals annual revenue for 2021 was 10.2M, 2.72% growth from 2020.
- NovaBay Pharmaceuticals annual revenue for 2022 was 14.4M, 41.16% growth from 2021.
On this page
Zippi applies for you, and finds you a job.
NovaBay Pharmaceuticals historical revenue
NovaBay Pharmaceuticals's peak revenue was $18.2M in 2017. The peak quarterly revenue was $2.6M in 2024(q1).
NovaBay Pharmaceuticals's revenue increased from $1.1m in 2014 to $14.4M currently. That's a 1,266.6% change in annual revenue.
NovaBay Pharmaceuticals annual revenue
NovaBay Pharmaceuticals annual revenue over time
| Fiscal year / year | NovaBay Pharmaceuticals revenue |
|---|---|
| 2014 | $1.1M |
| 2015 | $4.4M |
| 2016 | $11.9M |
| 2017 | $18.2M |
| 2018 | $12.5M |
| 2019 | $6.6M |
| 2020 | $9.9M |
| 2021 | $10.2M |
| 2022 | $14.4M |
Rate NovaBay Pharmaceuticals' financial transparency
NovaBay Pharmaceuticals annual growth
NovaBay Pharmaceuticals saw the greatest revenue growth in 2015, when revenue increased by 315.65%.
NovaBay Pharmaceuticals had the lowest revenue growth in 2019, when revenue changed by -47.24%.
NovaBay Pharmaceuticals annual growth rate over time
| Year | NovaBay Pharmaceuticals growth |
|---|---|
| 2015 | 316%↑ |
| 2016 | 172%↑ |
| 2017 | 53%↑ |
| 2018 | -31%↓ |
| 2019 | -47%↓ |
| 2020 | 51%↑ |
| 2021 | 3%↑ |
| 2022 | 41%↑ |
NovaBay Pharmaceuticals jobs nearby
Do you work at NovaBay Pharmaceuticals?
Is NovaBay Pharmaceuticals transparent about its revenue structure?
NovaBay Pharmaceuticals financial information
| CEO | Mark Sieczkarek |
| Company Type | Public |
| Employees Number | 25 |
| Date Founded | 2000 |
| Headquarters | Emeryville, California |
| Number of Locations | 1 |
| Revenue | $14.4M |
| Net Income | -$10,608,000 |
| Gross Proft | $7.8M (2022) |
| PE Ratio | -2.03 |
| Tax Rate | -0.0% |
| Market Capitalization | $21.5M |
| Total Assets | $16,399,000 |
| Ticker | NBY |
NovaBay Pharmaceuticals jobs you might like
NovaBay Pharmaceuticals financing
NovaBay Pharmaceuticals received early financing of $15.1M on 2015-03-19.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $15.1M | 03/2015 |
| Post Ipo Debt | $3M | 01/2016 |
| Post Ipo Equity | $2.8M | 02/2016 |
| Post Ipo Equity | $7.8M | 05/2016 |
| Post Ipo Equity | $6.0M | 02/2018 |
| Post Ipo Equity | $3M | 07/2019 |
| Post Ipo Equity | $15M | 11/2021 |
NovaBay Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Triton Funds LLC | Post Ipo Equity |
NovaBay Pharmaceuticals competitors
NovaBay Pharmaceuticals's top competitor, Merck, earned an annual revenue of $64.2B.
NovaBay Pharmaceuticals's smallest competitor is Inova Pharmaceuticals with revenue of $19.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 140 |
| Amneal Pharmaceuticals | $76,227 | $2.8B | 6,500 | 96 |
| Zoetis | $87,092 | $9.3B | 11,300 | 179 |
| SIGA Technologies | $71,494 | $115.5M | 43 | 1 |
| Merck | $90,328 | $64.2B | 74,000 | 1,947 |
| Amgen | $93,349 | $33.4B | 22,000 | 594 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 654 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Exelixis | $108,978 | $2.2B | 484 | 159 |
NovaBay Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
NovaBay Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of NovaBay Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NovaBay Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at NovaBay Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NovaBay Pharmaceuticals. The data presented on this page does not represent the view of NovaBay Pharmaceuticals and its employees or that of Zippia.
NovaBay Pharmaceuticals may also be known as or be related to NOVABAY PHARMACEUTICALS INC., NovaBay Pharmaceuticals, NovaBay Pharmaceuticals Inc, NovaBay Pharmaceuticals, Inc., Novabay Pharmaceuticals and Novabay Pharmaceuticals, Inc.